Kassim Javaid, Professor of Osteoporosis and Adult Rare Bone Diseases and lead investigator of the ADOPT study, will present expanded data from the study showcasing the clinical utility of the AI ...

clinical trials investigating therapies to preserve bone mass in the setting of AI use have been initiated. The monoclonal antibody to receptor activator of nuclear factor–κB ligand (RANKL ...